-
1.
公开(公告)号:US5552405A
公开(公告)日:1996-09-03
申请号:US509268
申请日:1995-07-31
IPC分类号: A61K31/40 , A61K31/44 , A61K31/4427 , A61K31/505 , A61P31/12 , A61P31/18 , A61P43/00 , C07D207/16 , C07D401/12 , C07D401/14 , C07D403/12 , C07D207/09
CPC分类号: C07D401/12 , C07D207/16 , C07D401/14
摘要: Disclosed herein are compounds of formula 1 ##STR1## wherein X is a terminal group, for example, an aryloxycarbonyl or an alkanoyl; B is absent or an amino acid residue, for example, Val or Asn; R.sup.1 is alkyl; and Y is a ring substituent, for example, benzyl, benzyloxy, phenylthio or 2-pyridinylthio. The compounds inhibit the activity of human immunodeficiency virus (HIV) protease and interfere with HIV induced cytopathogenic effects in human cells. These properties render the compounds useful for combating HIV infections.
摘要翻译: 本文公开了式1的化合物其中X是末端基团,例如芳氧基羰基或烷酰基; B不存在或氨基酸残基,例如Val或Asn; R1是烷基; Y为环取代基,例如苄基,苄氧基,苯硫基或2-吡啶硫基。 这些化合物抑制人类免疫缺陷病毒(HIV)蛋白酶的活性,并干扰人体细胞中HIV诱导的致细胞致病作用。 这些性质使化合物可用于抗艾滋病毒感染。
-
公开(公告)号:US07585845B2
公开(公告)日:2009-09-08
申请号:US10850101
申请日:2004-05-20
申请人: Montse Llinas-Brunet , Murray Bailey , Punit Bhardwaj , Josee Bordeleau , Pasquale Forgione , Elise Ghiro , Vida Gorys , Nathalie Goudreau , Sylvie Goulet , Teddy Halmos , Jean Rancourt
发明人: Montse Llinas-Brunet , Murray Bailey , Punit Bhardwaj , Josee Bordeleau , Pasquale Forgione , Elise Ghiro , Vida Gorys , Nathalie Goudreau , Sylvie Goulet , Teddy Halmos , Jean Rancourt
IPC分类号: A61K31/47 , C07D215/38
CPC分类号: A61K31/4709 , A61K38/06 , A61K38/212 , C07K5/0808 , C07K5/0827 , Y02A50/463 , A61K2300/00
摘要: Compounds of formula (I): wherein B, X, R3, L0, L1, L2, R2, R1 and RC are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.
摘要翻译: 式(I)化合物:其中B,X,R3,L0,L1,L2,R2,R1和RC如本文所定义。 该化合物可用作用于治疗丙型肝炎病毒感染的HCV NS3蛋白酶的抑制剂。
-
公开(公告)号:US20100087382A1
公开(公告)日:2010-04-08
申请号:US12527200
申请日:2008-02-15
申请人: Murray D. Bailey , Francois Bilodeau , Pasquale Forgione , Vida Gorys , Montse Llinas-Brunet , Julie Naud , Jeffrey O'Meara , Marc-Andre Poupart
发明人: Murray D. Bailey , Francois Bilodeau , Pasquale Forgione , Vida Gorys , Montse Llinas-Brunet , Julie Naud , Jeffrey O'Meara , Marc-Andre Poupart
CPC分类号: C07K14/81 , A61K38/00 , C07D207/16 , C07D403/10 , C07D405/10 , C07D409/10 , C07D413/10 , C07K5/0808 , C07K5/081 , C07K5/0812
摘要: Compounds of formula I: wherein R1, R2, R2a, R3, R4 and R5 are defined herein, are useful as inhibitors of the HCV NS3 protease.
摘要翻译: 式I化合物:其中R1,R2,R2a,R3,R4和R5如本文所定义,可用作HCV NS3蛋白酶的抑制剂。
-
公开(公告)号:US07939667B2
公开(公告)日:2011-05-10
申请号:US11766171
申请日:2007-06-21
申请人: Montse Llinas-Brunet , Murray Bailey , Punit Bhardwaj , Josee Bordeleau , Pasquale Forgione , Elise Ghiro , Vida Gorys , Nathalie Goudreau , Sylvie Goulet , Teddy Halmos , Jean Rancourt
发明人: Montse Llinas-Brunet , Murray Bailey , Punit Bhardwaj , Josee Bordeleau , Pasquale Forgione , Elise Ghiro , Vida Gorys , Nathalie Goudreau , Sylvie Goulet , Teddy Halmos , Jean Rancourt
IPC分类号: C07D215/38 , A61K31/02
CPC分类号: A61K31/4709 , A61K38/06 , A61K38/212 , C07K5/0808 , C07K5/0827 , Y02A50/463 , A61K2300/00
摘要: Compounds of formula (I): wherein B, X, R3, L0, L1, L2, R2, R1 and RC are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.
摘要翻译: 式(I)化合物:其中B,X,R3,L0,L1,L2,R2,R1和RC如本文所定义。 该化合物可用作用于治疗丙型肝炎病毒感染的HCV NS3蛋白酶的抑制剂。
-
公开(公告)号:US20050020503A1
公开(公告)日:2005-01-27
申请号:US10850101
申请日:2004-05-20
申请人: Montse Llinas-Brunet , Murray Bailey , Punit Bhardwaj , Josee Bordeleau , Pasquale Forgione , Elise Ghiro , Vida Gorys , Nathalie Goudreau , Sylvie Goulet , Teddy Halmos , Jean Rancourt
发明人: Montse Llinas-Brunet , Murray Bailey , Punit Bhardwaj , Josee Bordeleau , Pasquale Forgione , Elise Ghiro , Vida Gorys , Nathalie Goudreau , Sylvie Goulet , Teddy Halmos , Jean Rancourt
IPC分类号: A61K31/4709 , A61K38/00 , A61K38/21 , A61P31/00 , C07K5/08 , C07K5/083 , A61K38/05 , C07K5/06
CPC分类号: A61K31/4709 , A61K38/06 , A61K38/212 , C07K5/0808 , C07K5/0827 , Y02A50/463 , A61K2300/00
摘要: Compounds of formula (I): wherein B, X, R3, L0, L1, L2, R2, R1 and RC are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.
摘要翻译: 式(I)化合物:其中B,X,R 3,L 0,L 1,L 2,R 2,R 1和R C如本文所定义。 该化合物可用作用于治疗丙型肝炎病毒感染的HCV NS3蛋白酶的抑制剂。
-
-
-
-